| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2025 | Dec, 2025 |
| Sales | 10 | 690 | 280 | 0 | 0 |
| Sales Growth | -98.55% | +146.43% | unch | unch | unch |
| Net Income | -8,970 | -11,280 | -10,680 | 0 | 0 |
| Net Income Growth | +20.48% | -5.62% | unch | unch | unch |
Azitra Inc (AZTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Azitra Inc. is an early-stage clinical biopharmaceutical company. It focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Azitra Inc. is based in BRANFORD, Conn.
Fiscal Year End Date: 12/31